Celoxica has secured funds from Beringea Growth Finance. The business is a provider of ultra low-latency market data, order entry and pre-trade risk solutions and is headquartered in the UK with offices in Chicago, New York and Paris.
Celoxica, a leading provider of ultra low-latency market data, order entry and pre-trade risk solutions, has secured £1.5 million from Beringea Growth Finance, a provider of asset-based and working capital finance. Beringea Growth Finance is part of Beringea LLP, the manager of the ProVen VCTs.
Established in 1996 as a spinout of Oxford University, Celoxica has grown to become a leading provider of trading solutions to the global financial services industry. Headquartered in the UK with offices in Chicago, New York and Paris, the company’s clients include some of the top automated trading firms, banks and brokers in the U.S. and Europe.
Celoxica’s products optimize the performance of trading applications across multiple asset classes, including equity, options, futures, fixed income and FX markets. Using Field Programmable Gate Array (FPGA) technology, the company provides clients with the fastest method of accessing, understanding, distributing and responding to market conditions, even during the most demanding market spikes, when every microsecond matters.
Mark Taylor, head of Beringea Growth Finance, said: “Celoxica’s management team’s expertise combines a great knowledge of financial trading technology, with a deep understanding of how to apply FPGA technology to create best-in-class solutions for trading firms. We are pleased to support the company that is creating the worldwide standard for reliable, proven and ultra-low latency electronic trading.”
Jean-Marc Bouhelier, CEO of Celoxica, said: “The new investment will be used to support the operational growth of the business as we expand our presence globally and develop new market segments. We are delighted to work with Mark Taylor and the team at Beringea, who bring both their wealth of experience of private equity backed businesses in addition to expert knowledge and experience of providing debt.”
– ENDS –
Notes to Editors:
Celoxica is a leading provider of hardware accelerated low-footprint, ultra low latency market data, order entry and risk trading solutions for the global financial services industry. Headquartered in the UK with offices in Chicago and New York, Celoxica delivers trading solutions to automated trading firms, banks and brokers seeking to optimize the performance of their trading applications across multiple asset classes in all market conditions, whilst reducing their total cost of ownership.
Beringea is an international growth capital firm with offices in London and Michigan, U.S.A, which invests in high growth companies. Beringea’s London office manages a number of funds, including the ProVen VCTs.
Beringea is a generalist investor with sector expertise in Media, Healthcare and Retail. Beringea‘s previous investments have included Fjordnet, Espresso Education, Saffron Digital and Mergermarket.
Beringea LLP is authorised and regulated by the Financial Conduct Authority.
About Beringea Growth Finance
Beringea Growth Finance, as part of Beringea, is focused on providing asset based and working capital finance. It looks to provide facilities from £1 million to £5 million over repayment periods usually of 24 – 48 months.
About the ProVen VCTs
The ProVen VCTs (ProVen VCT, ProVen Growth & Income VCT and ProVen Planned Exit VCT) are funds raised under the government’s Venture Capital Trust scheme for supporting UK SMEs with equity investment. The original Ordinary share issues of ProVen VCT and ProVen Growth & Income VCT have generated higher Total Returns to investors than any other VCT share issues in their respective launch years